All lobbying filings
W STRATEGIES, LLC
W STRATEGIES, LLC filed a Q3 report for IPSEN BIOPHARMACEUTICALS, INC. on October 19, 2026, reporting $20,000 in lobbying income.
Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbying activity
1
Monitored Public Law 119-21: One Big Beautiful Bill Act. Issues related to drug pricing.